Bioanalysis Zone

Quick-fire interview on immunogenicity with Mohsen Rajabi (FDA)


MohsenMy name is Mohsen Rajabi. I am a Pharmacologist in the Division of New Drug Bioequivalence Evaluation (DNDBE), Office of Study Integrity and Surveillance, Office Translational Science, Center for Drug Evaluation and Research, US FDA. I conduct study-directed and comprehensive surveillance inspections of firms that conduct pharmacokinetic and bioavailability/bioequivalence (BA/BE) studies submitted to the FDA.

To view restricted content, please:

Back to immunogenicity


Leave A Comment